GSPT1 and colorectal cancer: We also show that the weak degradation of GSPT1 by CC-885correlates with a modest cell growth inhibition in HCT116 (IC50 =0.198 μM) (Figure 5C, Figure S5), highlighting that morepotent GSPT degraders could be used in colorectal cancer.60,61